8 completed. 8 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 8 | Completed 8 |
Follow ATX-101: new trials by email Literature Review of ATX-101 trials Research Report on ATX-101
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Safety Study of Deoxycholic Acid for the Reduction of Localized Subcutaneous Fat in the Submental Area in Subjects 65 to 75 Years of Age ATX-101, Placebo - Moderate to Severe Convexity of Submental Fat, Safety | Phase 3 | Completed | Kythera Biopharmaceuticals | 55 | 2014-04-01 | 2020-02-17 |
| Long-term Follow-up Study on Safety and Maintenance of Efficacy of ATX-101 ATX-101, Placebo - Submental Fat, Healthy | Phase 3 | Completed | Kythera Biopharmaceuticals | 224 | 2013-12-01 | 2020-02-17 |
| Patient Experience Study of Deoxycholic Acid Injection Deoxycholic Acid Injection, Placebo, Cold Compress - Moderate or Severe Submental Fullness | Phase 3 | Completed | Kythera Biopharmaceuticals | 84 | 2013-12-01 | 2015-07-28 |
| Phase 3 Study of Deoxycholic Acid Injection (ATX-101) Versus Placebo for the Reduction of Localized Subcutaneous Fat in the Submental Area Deoxycholic acid injection, Placebo - Moderate or Severe Submental Fullness | Phase 3 | Completed | Kythera Biopharmaceuticals | 516 | 2012-03-01 | 2015-06-15 |
| Phase 3 Study of Deoxycholic Acid Injection (ATX-101) Versus Placebo for the Reduction of Localized Subcutaneous Fat in the Submental Area Deoxycholic acid injection, Placebo - Moderate or Severe Submental Fullness | Phase 3 | Completed | Kythera Biopharmaceuticals | 506 | 2012-02-01 | 2015-06-15 |
| Open-Label Study of Deoxycholic Acid for the Reduction of Localized Subcutaneous Fat in the Submental Area Deoxycholic acid injection - Moderate or Severe Submental Fullness | Phase 3 | Completed | Kythera Biopharmaceuticals | 165 | 2011-08-01 | 2016-01-14 |
| Evaluation of Safety and Efficacy of Deoxycholic Acid Injection (ATX-101) in the Reduction of Submental Fat Deoxycholic acid injection, Placebo - Moderate or Severe Submental Fullness | Phase 3 | Completed | Kythera Biopharmaceuticals | 360 | 2011-01-01 | 2015-06-12 |
| Evaluation of Safety and Efficacy of Deoxycholic Acid Injection (ATX-101) in the Reduction of Submental Fat Deoxycholic acid injection, Placebo - Moderate or Severe Submental Fullness | Phase 3 | Completed | Kythera Biopharmaceuticals | 363 | 2010-12-01 | 2015-07-14 |
Kythera Biopharmaceuticals (8)
United States (6) · Canada (3) · Belgium (2) · France (2) · Germany (2) · Spain (2) · United Kingdom (2) · Italy (1)
Frederick Beddingfield, MD, PhD (4) · Frederick Beddingfield, III, MD, PhD (3) · Frederick Beddingfield, III, M.D., PhD (1)